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Abbreviations 
 
A2M   Alpha-2-macroglobulin 
APC   Allophycocyanin 
ARHGAP22  Rho GTPase-activating protein 22 
BSA                         Bovine serum albumin 
CD   Cluster of differentiation 
cDNA   complementary deoxyribonucleic acid  
CO2   Carbon dioxide  
CORO1B  Coronin-1B 
cRNA   complementary Ribonucleic acid  
CTL                         Control  
DEG                        Differentially expressed gene  
DMEM                     Dulbecco's modified eagle medium 
D-PBS                      Dulbecco's phosphate buffered saline 
ECD   Electron coupled dye, also called as PE-Texas Red 
ECM   Extracellular matrix 
EMF                        Electromagnetic field 
FBS    Fetal bovine serum  
FI   Fold increase 
FITC   Fluorescein 
FN1   Fibronectin 
HCl   Hydrogen chloride 
HLA-DR  Human leukocyte antigen D related 
IPA                  Ingenuity Pathway  
ISCT   International society of cellular therapies 
kHz   Kilohertz  
MFI                           Median fluorescence intensity 
MHz                Megahertz 
MMP1  Matrix metalloproteinase 1  
mPMS  1-methoxy-5-methyl-phenazinium methyl sulfate  
mRNA  messenger Ribonucleic acid  
MSC                         Mesenchymal stromal cells 
PC7    Phycoerythrincyanin 7 
PCR                   Polymerase chain reaction  
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PE   Phycoerythrin 
PD                            Population doubling 
PLAT   Tissue-type plasminogen activator 
P/S                     Penicillin/streptomycin 
QMR   Quantum Molecular Resonance 
RNA   Ribonucleic acid 
RUNX2  Runt-related transcription factor 2 
SD                            Standard deviation 
SEM   Standard error mean 
SHC1   SHC-transforming protein 1 
SLIT2   Slit homolog 2 protein 
SOX9   SRY-box 9 
TBP   TATA-box-binding protein 
WST-1 sodium5-(2,4-disulfophenyl)-2-(4-iodophenyl)-3- 
 (4nitrophenyl)- 2H tetrazolium inner salt 
YWHAZ  14-3-3 protein zeta/delta 
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Summary 
 
Effects of high frequency electromagnetic fields and electric currents on 
biological systems, in particular concerning stem cells, are not extensively 
studied. Medical devices based on Quantum Molecular Resonance (QMR) 
technology are actually used in clinical practice for the treatment of 
musculoskeletal disorders and post-surgical articulation conditions. QMR 
is a new technology based on the quantum theory and assumes that a 
quantum value of energy exists for breaking every type of molecular bond 
without any increase of temperature. QMR produces waves at high 
frequencies (4-64 MHz) and low intensity through oscillating electric 
currents.  
This work aimed at understanding how QMR acts on the regenerative 
capacities of human bone marrow mesenchymal stromal cells (MSC). MSC 
are multipotent non-hematopoietic cells with peculiar immunomodulatory 
and angiogenic properties and a supportive role in hematopoiesis. 
Moreover their capacity to be recruited in damaged tissues and to 
differentiate in tissues of mesodermal origin, make them suitable for 
cellular therapy and in regenerative medicine. MSC cultures were exposed 
to QMR for two cycles of treatment at two different nominal powers (40 
and 80) using an experimental medical device supplied and patented by 
Telea Electronic Engineering S.r.l. (Italy).  
QMR treatments maintained MSC identity and function in terms of 
morphology, phenotype and multilineage differentiation (adipogenesis, 
osteogenesis and chondrogenesis). Moreover the treatment did not affect 
cell viability or proliferation and preserved their intrinsic migration 
capacity. Microarray analysis revealed that QMR stimulation at 40 
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nominal power was likely more effective than 80 in inducing molecular 
changes, as demonstrated by the greater number of up- and down-
regulated genes. Specifically, it was observed that genes modulated at 40 
were involved into cellular and tissue regeneration processes like 
extracellular matrix (ECM) remodeling, angiogenesis, cellular migration 
and regulation of actin filaments. In this regard, quantitative real time 
PCR results confirmed  expression of MMP1, PLAT and A2M genes. These 
genes generate transcripts for secreted proteins and are involved in ECM 
remodeling through the fibrinolytic system, which is also implicated in 
embryogenesis, wound healing and angiogenesis.  
We conclude that QMR stimulation might favor tissue regeneration 
probably supporting neoangiogenesis. Further studies are needed to 
evaluate how these proteins are implicated in MSC regenerative response 
after QMR exposition.  
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Riassunto 
 
Gli effetti dei campi elettromagnetici e delle correnti elettriche ad alta 
frequenza sui sistemi biologici, in particolare nei confronti delle cellule 
staminali, non sono stati ancora studiati in modo approfondito. 
Strumentazioni mediche che si basano sulla tecnologia della Risonanza 
Quantica Molecolare (QMR) sono attualmente utilizzate nella pratica 
clinica per trattare patologie muscolo-scheletriche e traumi post-chirurgici 
alle articolazioni. La QMR è una nuova tecnologia che si basa sulla teoria 
dei quanti ed assume che esiste un valore quantico di energia capace di 
rompere ogni tipo di legame molecolare senza produrre un incremento di 
temperatura. La QMR genera onde ad alta frequenza (4-64 MHz) e a basse 
intensità mediante correnti elettriche oscillanti.  
Questo lavoro è focalizzato nella comprensione dei meccanismi alla base 
dell’azione della  QMR sulle capacità rigenerative di cellule mesenchimali 
stromali (MSC) umane ottenute da midollo osseo. Quest’ultime sono 
cellule multipotenti non ematopoietiche con peculiari proprietà 
immunomodulanti e di supporto all’ematopoiesi ed alla  neoangiogenesi. 
In virtù della proprietà di queste cellule di essere reclutate in presenza di 
un danno tissutale, esse trovano applicazione in protocolli di terapia 
cellulare e medicina rigenerativa.  
Le colture di MSC sono state esposte a due cicli di trattamento con QMR 
applicando due diversi settaggi noti come potenze nominali 40 e 80, 
mediante l’uso di uno strumento medico sperimentale fornito e patentato 
dalla Telea Electronic Engineering S.r.l. (Italia).  
In questo studio abbiamo dimostrato che il trattamento con QMR conserva 
l’identità e la funzione delle MSC in termini di morfologia, fenotipo e  
8 
 
capacità di differenziare in tessuto adiposo, osseo e cartilagineo. Inoltre la 
stimolazione non altera la vitalità o la proliferazione delle cellule e 
mantiene la loro intrinseca capacità migratoria. 
L’analisi mediante microarray ha suggerito una maggiore efficacia della 
stimolazione alla potenza nominale 40 nell’indurre cambiamenti a livello 
molecolare, come dimostrato dal maggior numero di geni up- e down-  
regolati. In modo specifico, è stato osservato che i geni modulati con il 
settaggio 40 sono coinvolti nei processi di rimodellamento della matrice 
extracellulare, angiogenesi, migrazione cellulare e regolazione dei 
filamenti actinici. Infine risultati ottenuti in real time PCR quantitativa 
hanno confermato l’espressione dei geni MMP1, PLAT e A2M. Questi geni 
producono trascritti per proteine secrete e sono coinvolti nel 
rimodellamento della matrice extracellulare attraverso il sistema 
fibrinolitico, il quale è implicato nell’embriogenesi, nella guarigione delle 
ferite e nell’angiogenesi. 
In conclusione, la stimolazione con  QMR potrebbe favorire la 
rigenerazione tissutale coinvolgendo probabilmente vie di segnale 
implicate nella neoangiogenesi. Successivi studi saranno necessari per 
valutare in modo approfondito come queste proteine possano essere 
implicate nella risposta rigenerativa delle MSC dopo esposizione con 
QMR.  
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1. Introduction 
 
 
1.1 Definition of electric and electromagnetic fields 
 
Electric field is a vector field caused by stationary electric charge and 
creates an electric current when modifies spatially through a flow of 
electric charges. Electric field is always associated with a magnetic field 
that changes over time and that is well described by Maxwell's equations. 
The combination of two fields perpendicular to each other, generates an 
electromagnetic field (EMF). Its propagation form is represented by 
electromagnetic waves which move out into space and compose the 
electromagnetic radiation consisting of photons. In other words 
electromagnetic radiation exhibits both wave and particle properties at the 
same time.  
Electromagnetic radiations are classified in the electromagnetic spectrum 
(Figure 1) in relation to their frequency (f), that is inversely proportional to 
wavelength (λ) and directly proportional to photon energy (E), following 
the formulas: f  = c / λ and E = f ∙ h, where (c) is speed of light in a vacuum 
and (h) is Planck’s constant. 
For several decades the diffusion of these fields, as a consequence of 
advances in technology, has been in depth discussed regarding the safety 
and degree of their influence in everyday life. In fact we are exposed to 
increasing numbers of EMFs including extra low-frequency EMFs from 
electric power lines, EMFs from cell phones and microwaves and many 
EMFs at mid-range frequencies like house appliances and remote controls.  
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Figure 1. Electromagnetic spectrum. The electromagnetic spectrum covers different 
frequencies including visible light. Radio frequency (3 Hz - 300 GHz) wavelengths are 
named originally based on their use in technology for radio communication and 
broadcasting. However, radio frequencies are used for many other applications 
nowadays, for example in medical treatments in the range extending from 3 kHz to 300 
GHz. Image obtained by Cifra et al. 2011 [1]. 
 
 
The effects of electromagnetic radiation upon biological systems  depend 
indeed both from the radiation's power and its frequency. Generally, 
radiations can be divided in 2 categories: ionizing and non-ionizing 
radiations. The first one is composed by ultraviolets, X-rays and gamma 
rays. They have the ability to cause chemical reactions and damage on 
living cells because they have enough energy to ionize molecules or affect 
chemical bonds. The second one consists in  radio waves, microwaves, 
infrared and visible light. Damages inflicted to cells and other materials 
are determined mainly by power and by heating effects generated from 
combined energy transfer of photons.  
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1.2 Interaction with biological systems 
 
Biological systems are composed by heterogeneous components as water, 
ions, soluble and insoluble molecules, macromolecules like proteins and 
membranes that have characteristic structures, sizes and properties.  All of 
these components staying in an aqueous environment show a different 
distribution of charges correlated to their function and play an important 
role in the biological effects. For this reason their structure can generate 
endogenous electric currents and EMFs, make them susceptible to external 
stimulation [2]. In fact the change of charge gradients creates currents 
inside the cells and initiates mechanisms of interaction and organization at 
various levels promoting different cellular pathways [3; 4]. In particular it 
is the case of cellular polar structure like cellular membranes, transport ion 
channels and cytoskeleton [5-7].  
Cellular membranes are no homogenous structures sensible to alterations 
in the transmembrane potential. The latter is established by the balance of 
intracellular and extracellular ionic concentration that generates voltage 
differences influencing transmission of both electrical and chemical signals 
across membranes to other tissues. Electric fields affect the selective 
transport of ions or molecules through the membrane changing the 
accumulation of charged ions layers at the surface (Figure 2) and the 
manner through which new molecules are incorporated or bound to 
membrane surface [8]. In the same manner cellular cytoskeleton and its 
complex structures are good candidates to respond at EMFs and electric 
currents. They are composed by heterodimeric highly polar subunits that 
are characterized by a perpetual assembly and disassembly. In particular, 
microtubules are capable of vibrations in kHz to GHz regions [1] 
becoming susceptible to eventually structure modification at this 
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frequency range. In addition Lee and co-workers [7] demonstrated that in 
the presence of an alternating current electric field, the direction of 
movement of actin filaments, on myosin coated substrate, is 
perpendicularly toward the electrode edges and that the alignment is 
frequency-dependent. 
 
 
 
Figure 2. Generation of electrophoresis force on charged species. Macromolecules with 
negative surface charge are forced toward the anode, while highly extracellular cations, 
as Na+, are forced toward the cathode. Arrows indicate the direction of the electrical force 
on charged species. Circles around proteins signify relative negative charge distribution. 
Image obtained by Messerli and Graham 2011 [9]. 
 
 
All of these factors play an important role in cellular pathways and tissue 
physiology demonstrating a therapeutic potential [4]. For this purpose a 
lot of aspects are studied after EMFs and electrical stimulation with 
differences in response related to the type of frequency range, particularly 
at low frequencies, and cellular models. They include promotion and 
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inhibition of cellular proliferation [10; 11], cellular viability to value 
adverse outcomes after treatments [12; 13], differentiation [14-16], cellular 
migration and motility [17-19], inflammatory response [20; 21] and gene 
expression profiles [22; 23]. 
 
 
1.3 Therapeutic application of electric  and  EMFs stimulation 
 
1.3.1 Methods and frequencies range of stimulation 
 
Four different modalities have been described to generate electrical fields 
and EMFs both in-vitro and in-vivo: direct current, capacitive coupling, 
inductive coupling and combined stimulation [24; 25] (Figure 3). 
Direct current is the simplest way of delivering electrical stimulation. It is 
applied through biocompatible electrodes which are directly connected to 
tissue or cell culture medium [26].  The use of this method allows control 
of electrical field in-vitro, but shows concomitant disadvantages. The 
direct contact between electrodes and cell medium can generate reactions 
as radical production or electrolysis and can introduce biological active 
ions that influence cells. This phenomenon makes difficult to  separate the 
real effect due to direct currents by artifacts [27].  
Capacitive coupling technique is created between two parallel layers that 
are placed above and below the culture medium with a non-conductive 
layer or air gap between them [28]. Its main advantages, consisting in 
avoiding the issues generated with direct current, can be limited by the 
high voltages required, which  increase with the distance between 
electrodes.   
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Inductive coupling approach is the most common method for applying 
electrical fields in-vivo and in-vitro. It is a non-invasive method consisting 
of a current-carrying coils which generates an EMF in the proximity of the 
targeted cells. There are numerous signal configurations concerning this 
stimulation modality and one of more common subtypes is known as 
pulsed electromagnetic field stimulation [29], where the stimulus is 
delivered in pulses and not continuously. 
 
 
 
Figure 3. The four main techniques of delivering electrical stimulation. They are the 
direct (A) and the indirect capacitive (B), inductive (C) and combined (D) methods. The 
latter is a combination of a static magnetic and an alternating current generated by a 
transient electromagnetic field. Image obtained by Balint et al. 2012 [25]. 
 
 
As reviewed by Markov [30], the therapeutic modalities of stimulation are 
also based on six groups depending by frequency:  
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- static/permanent magnetic fields created by permanent magnets or 
by passing direct current through a coil;  
- low frequency sine waves with frequency of 50-60 Hertz;  
- pulsed electromagnetic fields at low frequency with specific wave 
shapes and amplitude;  
- pulsed radiofrequency fields in the radiofrequency range (13.56,  
27.12 and 40.68 MHz);  
- transcranial magnetic/electric stimulation with short pulses (≤8 
Tesla); 
- millimeter waves at very high frequency range (30-100 GHz). 
 
1.3.2 Clinical applications  
 
In the last years the attention regarding the therapeutic application of 
EMFs and electric treatments in biomedical field and in regenerative 
medicine has undergone a huge raise. Several experiments support a role 
of electric fields in the stimulation of wound healing in frog nerula, 
salamander skin and mammalian cornea [31]. In particular, manipulation 
of electromagnetic environment seems to favors wound healing process, 
reduction of inflammatory state, angiogenesis and extracellular matrix 
(ECM) synthesis in humans [32]. By contrast, the mechanisms by which 
the fields improve healing are not known, complicating the use of any 
specific form of electrical stimulation and the optimization of the 
treatments [9]. For example EMFs are used in clinic in therapies for 
cutaneous ulcers with conflicting results. Some studies [33] described that 
patients affected by leg chronic varicose ulcers were treated using EMFs at 
very low frequencies during 15 minutes twice a week. In this case 
significant differences were not revealed in respect to patients that 
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received a conventional therapy, not considering a decrease in measure of 
wounds and in circumference of leg. By contrast, Canedo-Dorantes and 
co-workers [34] reported that, after EMFs treatments for 2-3 hours each 
day three times a week, 69% of wounds healed and more than 50% of 
patients healed in 4 months.  
Moreover, electrical and EMFs stimulation has been used for the treatment 
of bone disorders for many years as adjunctive therapy to promote bone 
healing [35]. It is clinically beneficial for bone fracture healing, treatment 
of osteoarthritis and pain reduction [35; 36]. Additional experimental 
studies confirm that EMFs stimulate osteogenesis, increase bone mineral 
density and decrease osteoporosis [37]. On the other hand a meta-analysis 
performed by Aleem et al. 2016 [35] suggests that the clinical evidence to 
support the use of electrical stimulators for bone healing has been 
inconclusive.  
 
 
1.4 Quantum Molecular Resonance theory and its related 
technology 
 
1.4.1 Quantum Molecular Resonance theory 
 
The theoretical basis of Quantum Molecular Resonance (QMR) assumes 
that a quantum value of energy is able to break every type of molecular 
bond without increasing of kinetic energy of hit molecules that induces 
rise in the temperature [38].  
The quantum of electromagnetic wave owns energy equal to E = h ∙ f, 
where (h) is Planck’s constant and (f) is frequency of wave. According to 
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Quantum Physics, a system absorbs energy by “packets” also called 
quanta energy. Consequently a molecular bond can absorb this type of 
energy where the amount depends by frequency of the wave. In other 
words the required quanta energy for breaking a molecular bond has to be 
equal, i.e. in resonance, to the energy of that bond (Em) following the 
formula: Em = k x f, where (k) is a constant that depends from the type of 
the wave and (f) is the frequency of wave.  
The efficiency of QMR, meaning the capacity of breaking the major 
number of chemical bonds, is based on the induction of more frequencies 
producing different quantum energies. QMR generators deliver no 
ionizing waves at high frequencies (4-64 MHz) and low intensity through 
alternating electric currents. 
 
1.4.2 QMR related technology 
 
QMR technology has been translated into medical devices by Telea 
Electronic Engineering S.r.l. (Sandrigo, VI, Italy).  
The molecular resonance scalpel Vesalius® is used in surgical purposes 
for cutting tissues and/or for contemporary coagulation to block bleeding 
[39; 40]. They are generated by rising of temperature (approximately 63°C) 
of tissues without necrosis plug and produced by energy concentrated on 
the tip of scalpel. 
The medical device Rexon-age® is adopted for improving post-traumatic 
tissue regeneration and exploits an elevated power density distributed on 
the surface of the electrodes adhering to the areas of interest. Today this 
device is mainly used in clinic for the treatment of musculoskeletal 
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disorders (inflammations, muscle tears and joint pains) and post-surgical 
articulation conditions [41; 42]. 
 
1.4.3 Previous study of QMR effects on muscle fibers 
 
Dal Maschio and colleagues [43] provide the first description of the 
behavior of muscle fibers exposed to QMR. They observed that high 
power stimulation produced a fast and well localized cut of the fibers and 
that low power stimulation caused a reversible deformation of the 
membrane. This deformation was accompanied by a membrane 
depolarization and an increase of cytosolic free calcium, which were 
detected by  fluorescent probes. Both the changes of membrane potential 
and the variations of free calcium concentration strictly followed the time 
course of electrical field application and removal.  
 
 
1.5 Mesenchymal stromal cells  
 
Mesenchymal stromal cells (MSC) are multipotent non-hematopoietic 
cells. MSC can be isolated from different adult and fetal tissues as bone 
marrow, umbilical cord, placenta, adipose tissue and synovial fluid. 
Dominici and co-authors [44] have established minimal criteria to define 
MSC: plastic adherence, specific surface antigen expression and 
multipotent differentiation potential in-vitro with adequate culture 
condition into adipocytes, osteocytes and chondrocytes. Recently this 
definition has appeared restrictive implicating the need of new 
approaches for the nomenclature, definition and characterization of MSC 
[45]. MSC have obtained relevant attention for their particular properties 
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(Figure 4) such as secretion of trophic and paracrine factors [47], 
regulation of immune response, anti-apoptotic effects and angiogenesis 
[48] and capacity to be recruited in damaged tissues [49; 50]. Most of  these 
functions are the result of an induced response to tissue or cell culture 
environment. For example MSC need to be ‘primed’ by inflammatory 
cytokines to become immunosuppressive [51] or mechanically stimulated 
to create an angiogenesis-promoting environment [52].  
 
 
 
Figure 4. Paracrine effects of cultured MSC. This mechanism can be divided into six 
main actions: immunomodulation, anti-apoptosis, angiogenesis, support of the growth 
and differentiation of local stem and progenitor cells, anti-scarring and chemoattraction. 
Image obtained by Singer et al. 2011 [46]. 
 
 
The availability and versatility of MSC make them an excellent treatment 
option for a wide variety of clinical settings [53]: from orthopedics and 
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spine therapies, to cardiovascular therapies,  wound care and soft tissue 
repair, neural disorders, spinal cord injury and  autoimmune disorders.  
Accumulated data indicate that MSC support healthy physiologic 
functioning towards successful healing, suggesting a role in all the three 
phases of wound healing represented by inflammation, proliferation and 
remodeling [54].  
 
 
 
Figure 5. MSC roles in each phase of the wound healing process.  Image obtained by 
Maxson et al. 2012 [54]. 
 
 
As illustrated in Figure 5, MSC promote the transition from inflammatory 
to proliferative phase, particularly critical for treating chronic wounds 
where high levels of inflammation prevent healing. MSC also contribute to 
proliferative phase by expressing growth factors as vascular endothelial 
growth factor (VEGF), hepatocyte growth factor (HGF), and platelet-
derived growth factor (PDGF) to promote epithelialization. Finally, MSC 
regulate remodeling of healed wound through the regulation and 
organization of ECM deposition. Badiavas and colleagues [55] 
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demonstrated that MSC can be successful in the treatment of non-healing 
chronic wounds. In similar way in a clinical randomized study [56] on 24 
patients with non-healing ulcers, the implant group had significant 
improvement in pain-free walking distance and reduction in ulcer size 
after 12 weeks. 
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2. Aim 
 
 
Medical devices based on QMR technology are actually used for the 
treatment of musculoskeletal disorders and post-surgical articulation 
conditions [41; 42].  
Effects of high frequency EMFs and electric currents on biological systems, 
in particular concerning stem cells, are not extensively studied.  
QMR exploits high frequency waves between 4 and 64 MHz at low 
intensity delivered through alternating electric currents. Because few data 
are available from the  literature on this technology and on QMR 
frequency range, our work was focused on understanding how QMR acts 
on the regenerative capacities of human bone marrow-derived MSC. 
These latter represent a promising cell-based therapeutic approach in 
regenerative medicine [49]. In particular it was demonstrated that 
endogenous bone marrow-derived MSC were recruited and mobilized to 
sites of injury [57] suggesting the importance of studying QMR exposition 
on this cell type.  
This study evaluated the effects of QMR on the identity and function of 
MSC. In first instance, we have investigated in-vitro MSC morphology, 
phenotype, multi-differentiation potential, viability, cellular proliferation 
and migration. Moreover, we analyzed at a molecular level relevant 
pathways possibly involved in QMR effects, by using microarray 
technology and quantitative real time PCR. 
MSC cultures were exposed to QMR using an experimental medical 
device supplied and patented by Telea Electronic Engineering S.r.l. (Italy). 
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3. Materials and methods 
 
 
3.1 Isolation and culture of MSC  
 
MSC were isolated starting from human bone marrow washouts of 
discarded bags and filters used for allogeneic transplantation. The 
procedure was approved by the ethics committee of San Bortolo Hospital, 
Vicenza, Italy. After 2 washing steps with 200 ml saline solution and 
centrifugation at 2.000 rpm for 10 min, whole unprocessed total nucleated 
cells were seeded in toto at the density of 1x105 cells/cm2 in low-glucose 
Dulbecco’s modified Eagle’s medium (DMEM) with GlutaMAXTM and 
pyruvate (Gibco, Thermo Fisher Scientific), supplemented with 10% fetal 
bovine serum (FBS, Qualified Australian, Gibco, Thermo Fisher Scientific) 
and 1% penicillin/streptomycin (P/S, Sigma-Aldrich). Cultures were 
incubated at 37°C in a humidified atmosphere with 5% CO2. Non-adherent 
cells were removed after 72 hours and fresh medium was added, then 
culture medium was changed every 3-4 days. At 80% confluence, MSC 
were washed with Dulbecco’s phosphate buffered saline (D-PBS, Sigma-
Aldrich), harvested using 10X TrypLE Select (Gibco, Thermo Fisher 
Scientific) and sub-cultured at a density of 1500 cells/cm2. For QMR 
experiments, MSC samples were seeded in 35 mm-diameter Petri dishes 
(CELLSTAR®, Greiner Bio-One) and passage numbers 4-6 were used.  
The cultures were observed with an inverted light microscope Axiovert 40 
CFL (Carl Zeiss) and the images acquisition obtained by AxioCam Mrm 
camera system (Carl Zeiss).  
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3.2 QMR stimulation protocol 
 
MSC cultures were exposed to QMR using an experimental medical 
device supplied and patented by Telea Electronic Engineering S.r.l. (Italy). 
The prototype worked with the following parameters:  
● Alimentation: 230 V ~ 50/60 Hz; 
● Maximum power in input: 250 VA; 
● Power in output: 45 W/400 Ω. 
The rise of effective powers delivered in output corresponded to increase 
in value of the nominal powers employed as QMR settings. In detail, the 
prototype enhanced alternating electric currents characterized by high 
frequency waves and low intensity, where the fundamental wave was at 4 
MHz and the subsequent ones increased in harmonic content until 64  
MHz. 
The exposure system was composed by a pair of custom made sterilized 
spheroidal electrodes of 35 mm-diameter and by a metallic plate. The 
electrodes were collocated inside 2 different Petri dishes and supported by 
polyvinyl chloride (PVC) component to allow the direct contact with the 
surface of culture medium. The metallic plate was positioned externally to 
the bottom of Petri dishes (Figure 6 A).   
After 72 hours from initial seeding, complete medium was changed. MSC 
cultures were undergone at 2 QMR cycles of stimulation, for 10 
minutes/day for 4 consecutive days (Figure 6 C). Cells were treated at 2 
different QMR settings corresponding to 40 and 80 nominal powers, with 
each condition performed in duplicate (Figure 6 B). 
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Figure 6. QMR stimulation protocol. A) Image of exposure system. B) and C) Scheme of 
QMR treatment. Cells were seeded on day 0, harvested and reseeded on day 7. The first 
cycle of treatment started on day 3 (black arrows), the second one on day 10 (blue 
arrows), 10 minutes/day for 4 consecutive days at 40 or 80 nominal powers. Sham-
exposed controls were kept in parallel.  
 
 
3.3 MSC phenotype characterization  
 
MSC phenotype was characterized by flow cytometry before and after 
QMR stimulation. Briefly, 1x105 cells were incubated with the following 
monoclonal antibodies: CD90-FITC (clone F15-42-1-5), CD105-PE (clone 
1G2), CD45-ECD (clone J.33), HLA-DR-APC (clone IMMU 357) (all 
purchased from Beckman Coulter) and CD73-PC7 (clone AD2) (Becton 
Dickinson) for 15 minutes protected from light at room temperature. After 
a wash with D-PBS to eliminate the surplus of antibodies, cells were 
suspended in D-PBS with 1% bovine serum albumin (BSA, Miltenyi 
Biotec). At least 20.000 cells were acquired on a FC500 flow-cytometer 
(Beckman Coulter) and data were analyzed by Kaluza software (Beckman 
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Coulter). The expression of each marker was assessed as percentage (%) of 
positive cells and as fold increase (FI), this latter defined as the ratio 
between the median fluorescence intensity (MFI) of the marker and its 
specific negative control.  
 
 
3.4 Multilineage differentiation 
 
After two cycles of consecutive stimulations the maintenance of MSC 
differentiation potential was tested. Samples were harvested and re-
seeded in 24-well plates (Falcon®, Corning Life Sciences) in presence of 
sterile circular coverslips (13 mm-diameter and 0.2 mm-thickness, Thermo 
Scientific Nunc) at the density of 4.000 cells/cm2. Differentiation was 
induced at semi-confluence with specific differentiation media for 21 days 
(StemPro Adipogenesis kit, StemPro Osteogenesis kit, StemPro 
Chondrogenesis kit, Gibco, Thermo Fisher Scientific). Fresh medium was 
added every 3 days and the respectively controls were maintained in 
parallel with the standard expansion medium (DMEM + 10% FBS + 1% 
penicillin/streptomycin).  
To detect the formation of lipid droplets, cells were fixed in 10% formalin 
for 5 minutes and stained with Oil Red O (Diapath Spa). Briefly, the 
samples were incubated for 10 minutes with Oil Red O solution. After 
abundant washing, the coverslips were covered with 10 drops of Mayer’s 
haematoxylin for 3 minutes and then washed with deionized water.   
The presence of calcific deposition as expression of osteogenic induction 
was analyzed through Alizarin red staining. The samples were washed 
with D-PBS and fixed in ice-cold 70% ethanol at 4°C for 1 h. Then, they 
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were incubated for 15 minutes with Alizarin red solution (0.02 g/ml 
filtered; Sigma-Aldrich) at room temperature. Finally, several washes were 
performed with deionized water. 
To verify chondrogenic differentiation, cells were fixed in 10% formalin 
for 5 minutes and stained with Alcian blue (1 g/l in 0.1 M HCl) for 2 h at 
room temperature. At the end of the staining, specific for acidic 
polysaccharides, the coverslips were rinsed extensively with deionized 
water. 
After each staining, the coverslips were mounted on microscope slides 
using Kaiser’s glycerol gelatine pre-warmed at 37°C. The acquisition of 
images was obtained by AxioCam Erc 5s camera system (Carl Zeiss). 
 
 
3.5 Assessment of cellular viability 
 
Cellular viability was determined by flow cytometry using LIVE/DEAD® 
Fixable Far Red Dead Cell Stain kit (Invitrogen™, Thermo Fisher 
Scientific). The reactive dye was able to permeate the compromised 
membranes of dead cells reacting with free amine both intracellularly and 
on cell surface. This way, dead cells resulted brighter in fluorescence in 
respect of viable cells (Figure 7). 
Briefly, QMR-treated samples were harvested and 1x105 cells were used 
for the assay. The cellular suspensions were rinsed once with D-PBS and 
suspended in 100 µl D-PBS. 10 µl of diluted 1:100 dye were added into the 
suspensions before incubation at room temperature for 30 minutes 
protected from light. After washing with D-PBS supplemented with 1% 
BSA, the samples were re-suspended in 100 µl of D-PBS + 1% BSA and 
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acquired on a FC500 flow-cytometer. Data were analyzed as % of dim or 
bright positive cells by Kaluza software. 
 
 
Figure 7. LIVE/DEAD® assay. This assay is based on the reaction between a fluorescent 
reactive dye and cellular amines. Live and dead cells can be distinguished easily by flow 
cytometry with a difference in fluorescent intensity typically greater than 50-fold. Image 
was obtained and modified by manufacturer’s guide. 
 
 
3.6 Quantification of cellular proliferation 
 
QMR effects on cellular proliferation were determined in two ways:  
1) measuring the Population Doubling (PD)  
2) performing the WST-1 assay (Sigma Aldrich).  
PD is an accurate estimation of cell growth that considers  the number of 
duplications of a given population from initial seeding. PD was evaluated 
using Trypan blue exclusion test and according to the following formula:  
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PD = [log (Nf) – log (Ni)] / log 2, where (Nf) represents the number of 
harvested cells and (Ni) the number of initially seeded cells. 
WST-1 is a tetrazolium negatively charged disulfonated inner salt 
containing an iodine residue. It is reduced extracellularly to its soluble 
derivative formazan by electron transport across the plasma membrane of 
dividing cells via the electron mPMS carrier (Figure 8). The reduction of 
WST-1 is directly proportional to the number of  metabolically activated 
cells in exponential growth phase [58].  
 
 
 
Figure 8. Schematic representation of the reduction mechanism of WST-1. Image 
extracted from Berridge et al. 2005 [58].  
 
 
In detail, at the end of 2 consecutive cycles of QMR treatment, samples 
were harvested, counted with Trypan blue and seeded in 96 well-plates 
(Falcon®, Corning Life Sciences) at the density of 2000 cells/well in a final 
volume of 100 µl/well of culture medium with eight replicates per 
condition. After 72 hours 10 µl/well of the probe WST-1 were added and 
plates were incubated for 3 hours at 37°C. Finally, the plates were read by 
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a spectrophotometer (SpectraCountTM Packard) at 450 nm wavelength to 
measure the absorbance of samples. Data were expressed as % 
proliferation on the control. 
 
 
3.7 Scratch test migration assay 
 
Cells were harvested and re-seeded in 24 well-plates at a density of 1x104 
cells/well in triplicate conditions. At 100% of confluence, vertical scratches 
were performed using 1000 µl plastic sterile tips (Sarstedt) to create a gap 
of about 1 mm. To eliminate dislodged cells, culture medium was 
removed and wells were washed with 1 ml of DMEM. New complete 
medium was added. Images of scratches were taken at different time 
points (Figure 9) and analyzed using Zen pro 2012 software (Carl Zeiss). 
The results were calculated as: % Closure = [(Area t0 – Area tx)/ Area t0] x 
100 , where t0 represented the initial scratch area and tx the time course 
scratch area. 
 
 
 
 
Figure 9. Scheme of scratch test migration assay. A wound was created into a monolayer 
of confluent MSC culture and the cell-free area was measured at specific time points (0 h, 
18 h, 24 h and 42 h). 
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3.8 Microarray analysis 
 
The RNA derived from 5 different MSC samples exposed to 1 cycle of 
QMR stimulation were extracted using RNeasy plus mini kit (Qiagen) 
according to the manufacturer’s instructions. The total RNA quantification 
was obtained with NanoDrop UV-VIS Spectrophotometer (Thermo Fisher 
Scientific). Microarray analysis was performed in collaboration with High 
Throughput Screening facility of the Centre for Integrative Biology 
(CIBIO, Trento, Italy), where the microarray experiments were performed.  
The quality of RNA was determined using Agilent 2100 Bioanalyzer 
system with Eukaryote Total RNA Nano kit (Agilent Technologies). The 
samples were processed according to protocol ”Agilent One-Color 
Microarray-based Gene Expression Analysis (Low Input Quick Amp 
Labeling)” with Human GE 4x44K V2 Microarray Kit with SurePrint 
technology (Agilent Technologies) illustrated schematically in Figure 10.  
Briefly, cDNA was synthesized by 200 ng of RNA in presence of RNA 
Spike-In (technical probes control) and then transcripted into 
complementary RNA (cRNA), marked during the reaction with cyanine 3 
dye. The cRNAs were purified with RNeasy columns (Qiagen) and 
fragmented with specific buffers coupled to heat. The hybridization 
between the samples and the microarray slides was performed for 17 
hours at 65°C. After washing steps to remove unspecific binding, the 
microarray slides were detected with Agilent scanner through 
ScanControl software. The translation from hybridization signal into 
numeric format was produced by Agilent Feature Extraction software.  
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Figure 10. Microarray workflow for samples preparation and arrays procession 
according to manufacturer’s protocol. Image obtained and modified by manufacturer’s 
guide. 
 
 
Afterward data were subjected to a pre-processing step consisting in 4 
phases: background subtraction, normalization, removal of probes 
according to flag quality and addition of the replicated probes. The quality 
of signals of hybridization was visualized through MA plot graphics that 
compared hybridization signals of all probes of one sample in respect of 
all probes of the other samples. Three out of the 16 samples (15 samples + 
1 technical replicate) showed an aberrant hybridization and they were not 
used for the analysis of the differentially expressed genes this latter 
elaborated with open-source program Bioconductor [59].  
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3.9 Quantitative real time PCR 
 
MSC cultures were exposed or not to QMR at 40 nominal power for 1 
cycle and the total RNA was extracted using RNeasy Plus Mini Kit 
(Qiagen) following the manufacturer’s instructions. Quality and quantity 
were determined using Nanodrop UV-VIS Spectrophotometer (Thermo 
Fisher Scientific). cDNA was synthesized in 20 µl reaction volume with 
800 ng of total RNA using the iScript cDNA synthesis kit (Bio-Rad 
Laboratories) according to the manufacturer’s instructions.  
The obtained cDNA was diluted 1:10 and the quantitative real time PCR 
experiments were performed using SsoFast EvaGreen Supermix with Low 
Rox (Bio-RAD Laboratories) on ABI 7500 Real-Time PCR System (Applied 
Biosystem, Thermo Fisher Scientific). The investigated genes were shown 
in Table A and primers used for the amplification were validated and 
obtained by Bio-RAD Laboratories. The protocol consisted of 30 seconds at 
95°C, 40 cycles of 5 seconds at 95°C and 32 seconds at 60°C, followed by a 
final melting step to evaluate the quality of product. Each gene was tested 
in three replicates. Data acquisition was obtained by SDS v1.2 software 
(Applied Biosystem, Thermo Fisher Scientific) and the relative expression 
was determined using 2-ΔΔCt method [60] with TBP and YWHAZ as 
reference genes [61]. 
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Gene name UniGene ID RefSeq 
MMP1 Hs.83169 NM_002421 
PLAT Hs.491582 NM_000930 
SLIT2 Hs.29802 NM_004787 
ARHGAP22 Hs.655672 NM_021226 
A2M Hs.212838 NM_000014 
CORO1B Hs.6191 NM_020441 
SHC1 Hs.433795 NM_183001 
FN1 Hs.203717 NM_054034 
RUNX2 Hs.535845 NM_001024630 
SOX9 Hs.647409 NM_000346 
TBP Hs.590872 NM_003194 
YWHAZ Hs.492407 NM_145690 
 
Table A. List of genes used for quantitative real time PCR experiments. In the table 
gene name, UniGene database identification code (UniGene ID) and NCBI Reference 
Sequence Database code (RefSeq) of genes used for quantitative real time experiments 
with SYBR® Green method were illustrated.  
 
 
3.10 Statistical analysis 
 
To analyze the differences between the experimental settings and the 
sham-exposed controls after both QMR cycles, data were analyzed by one-
way ANOVA followed by Dunnett's multiple comparison post-hoc test. 
Quantitative real time PCR data were analyzed by paired t-test comparing 
the ΔCt values at 40 with the controls. Statistical analysis was performed 
using GraphPad Prism version 5.01 (GraphPad Software). Differences 
between samples were considered statistically significant at p<0.05. 
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For microarray data analysis the “R language limma package” was used to 
identify the differentially expressed genes (DEG) [59], with Bayes’ 
empirical method considering the provenience of lots (paired test). 
Differences between conditions were considered significant after Benjamin 
& Hochberg correction at p<0.05. To analyze the best enrichment of gene 
lists, the ToppGene Suite and Ingenuity Pathway Analysis (IPA) programs 
were applied, considering q-value<0.01 with FDR Benjamin & Hochberg 
correction and p-value<0.01 with Bonferroni-Hochberg correction, 
respectively. 
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4. Results 
 
 
4.1 Analysis of cellular morphology  
 
MSC morphology was observed daily before and after QMR treatments at 
the different settings. The cells conserved their canonical fibroblast-like 
spindle-shaped aspect during all the time of the experiments (Figure 11), 
with no cells in suspension or in semi-adherence that could indicate a 
QMR induction to cellular death. No other signs of alteration in cell size, 
multinuclear cells and cytoplasmic granulations were present.   
 
 
 
 
Figure 11. MSC morphology after QMR stimulation. The images were obtained after 10 
minutes of QMR stimulation. A) Day 5 (first cycle of treatment); B) Day 12 (second cycle 
of treatment). Scale bar = 100 µm. Total magnification = 100X. One representative 
experiment was shown.  
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4.2 Analysis of MSC surface markers 
 
Phenotypic MSC characterization after the first and second cycle of 
treatment with QMR was performed by flow cytometry in agreement with 
ISCT criteria [45]. Particularly, the expression of CD90, CD105 and CD73 
on gated MSC was always over 95%, while that of CD45 and HLA-DR 
constantly lower than 2% (Table B). 
As shown in Figure 12, each marker showed inter-batches biological 
variability without statistical significance between treated and untreated 
samples after 1 and 2 cycles of stimulation. 
 
 
% Positive 
cells First cycle of treatment Second cycle of treatment 
QMR 
setting 40 80 CTL 40 80 CTL 
CD90-FITC 99,92 ± 0,09 99,87 ± 0,17 99,87 ± 0,13 99,44 ± 0,49 99,52 ± 0,36 99,48 ± 0,37 
CD105-PE 99,98 ± 0,01 99,98 ± 0,02 99,98 ± 0,01 99,79 ± 0,23 99,84 ± 0,15 99,79 ± 0,23 
CD73-PC7 99,98 ± 0,01 99,98 ± 0,01 99,99 ± 0,01 99,81 ± 0,20 99,87 ± 0,12 99,80 ± 0,23 
CD45-ECD 0,33 ± 0,15 0,31 ± 0,13 0,42 ± 0,34 0,25 ± 0,30 0,28 ± 0,30 0,21 ± 0,20 
HLA-DR-
APC 2,44 ± 1,82 2,17 ± 1,74 2,11 ± 1,23 1,39 ± 1,02 1,07 ± 0,77 0,97 ± 0,65 
 
Table B. MSC flow cytometry analysis after QMR stimulation at different settings. A 
five color combination of monoclonal antibodies was used to verify MSC identity 
according to the above listed surface markers. Data are presented as mean ± SD of 3 
independent experiments. 
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Figure 12. Fold increase of MSC markers after QMR stimulation at different settings. 
A) First cycle of treatment; B) Second cycle of treatment. Bars represented the maximum, 
median and minimum values of 3 independent experiments. The y-axis was in log10 
scale.  
 
 
4.3 Analysis of MSC differentiation potential 
 
To investigate the in-vitro differentiation potential of MSC after 2 cycles of 
QMR treatment, cells were induced or not to differentiate down the 
osteogenic, adipogenic and chondrogenic lineages, by using defined 
 media components and culture conditions
osteogenic, adipogenic and chondrogenic differentiation after 3 weeks of 
induction, being positive to Alizarin Red, Oil Red O and Alcian blue 
stainings (Figure 1
QMR-treated and non
observed after 1 cycle of stimulation (data not shown). 
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Figure 13. Adipogenic, osteogenic and chondrogenic differentiation after 2 QMR cycles 
of stimulation. Panels display one representative experiment showing the final outcome 
in MSC multilineage differentiation after 21 days of induction. QMR-treated (at 40 and 80 
nominal powers) and untreated samples (CTL) were induced (+) or not (-) to 
differentiation. Osteogenic, adipogenic and chondrogenic differentiation were assessed 
using Alizarin Red, Oil Red O and Alcian Blue stainings, respectively. Scale bar =100 µm. 
Total magnification = 100x. 
 
 
4.4 Effect of QMR stimulation on cellular viability  
 
Cellular viability in treated/untreated MSC was quantified by flow 
cytometry at the end of each cycle (Figure 14). Data showed that viability 
was not affected by QMR; indeed, more than 95% of cells were alive 
similarly to the controls, with low variability between the different MSC 
batches and settings. These results confirmed the morphological 
observations.  
 
 
 
Figure 14. Cellular viability after QMR treatment. Histograms represent the % of 
cellular viability after two cycles of QMR treatment at the different settings compared to 
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the sham exposed controls. Data are shown as mean ± SD of 3 independent experiments. 
No statistical differences were found between conditions. 
 
 
4.5 Effect of QMR on MSC proliferation  
 
As shown in Figure 15, replication of MSC cultures was not affected by 
QMR. In detail, our results showed no significant differences in the PD 
between controls and QMR-treated samples, at the different settings and 
times (Figure 15, A). In the same way WST-1 assay revealed no significant 
effects due to QMR exposition. By normalizing all values on the respective 
controls, mean values were about 101% and 107% of MSC proliferation 
obtained treating with 40 setting after 1 and 2 cycles, respectively. At 80 
setting the percentages of proliferation were 104% and 99%, respectively 
(Figure 15, B).  
 
 
 
A 
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Figure 15. Cellular proliferation after QMR stimulation. A) PD were assessed using 
Trypan blue exclusion test after the two cycles of QMR at day 7 and 14, respectively; B) 
Percentages of cellular proliferation on the controls were obtained by WST-1 assay after 
72 hours. Data are represented as mean ± SD of n=6 independent experiments.  
 
 
4.6 Effect of QMR stimulation on MSC migration 
 
QMR treatment after two cycles at the different settings did not modify 
the migration capacity of MSC. The gap closure evaluated at defined time 
points occurred without changes compared to the sham exposed samples 
(Figure 16). More in detail, cell cultures reached about 50% of closure after 
only 18h, thus showing the high capacity of MSC to proliferate after 
damage regardless of QMR treatment.  
 
    
 
 
 
 
 
 
 
B 
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Figure 16. Scratch test migration assay. After the creation of a gap on a MSC monolayer, 
cell cultures were monitored at 0 h, 18 h, 24 h and 42 h. A) First cycle of treatment; B) 
Second cycle of treatment. Mean ± SD of n=3 independent experiments. 
 
 
 
 
 
 
 4.7 Microarray analysis
 
Based on previous results, we studied at a molecular level the effect of 
QMR on MSC performing
QMR treatment (Day 7). 
Pre-processing microarray data ana
transcripts from 28000 to 12600. Thereafter, samples were grouped on the 
basis of the similarity of gene expression profiles (Figure 1
clustering showed that samples grouped mainly according to the donor’s 
provenience and not on the basis of QMR treatments, as a result of a 
inherent biological variability between 
Noteworthy, 3 out of 16 samples grouped independently of the MSC batch 
or QMR stimulation, due to an aberrant hybridization p
observed during pre-processing analysis (arrows in Figure 1
 
Figure 17. Clustering graphic of samples according to similarity of gene expression 
profiles. Image showing all the grouped samples after the pre
be identified in relation to each MSC batch. The arrows indicate the aberrant hybridized 
samples.  
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The differentially expressed genes (DEG) analysis was employed to 
identify the differences between QMR
cultures (Table C). 
and 987 down-regulated genes were found when using 40 as nominal 
power. At 80, 163 genes were found up
regulated.  
 
 
Table C. Up- and down
elaboration of the results was assessed by comparing QMR
QMR at 40 and 80 nominal powers) with untreated control cultures.
 
 
The best enrichment of gene lists was studied using ToppGene Suite and 
Ingenuity Pathway An
processes potentially associated with QMR stimulation.
allowed us to identify several cellular pathways involved in QMR and to 
restrict the number of genes for subsequent analysis. Notewor
majority of genes had low values of significance (Figure 1
down-regulated genes at 40 nominal power were reduced of 61% and 66%, 
respectively. At 80, the majority (83%) of up
down-regulated genes w
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A       Before      After                                                      
 
 
B                          Before                                                       After 
 
 
Figure 18. Dot plots of differentially expressed genes after QMR stimulation at 40 and 
80 nominal powers. Images illustrated the distribution of (A) 40 and (B) 80 up- and 
down-regulated genes before and after the exclusion determined by the best enrichment 
of gene lists. The y-axis was in log10 scale. 
 
As illustrated in Table D, 20 enrichment lists could be recognized 
associated with 40 nominal power (13 up-regulated and 7 down-
regulated), while only 4 (all traceable to up-regulated genes) were found 
associated with 80. The main biological processes affected by QMR 
stimulation belonged to cellular, tissue and cardiovascular development 
categories. In particular, cellular development recurred in 40 and 80 
dependent up-regulation and in 40 derived down-regulation.  
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Moreover, 2 arbitrary and more restrictive parameters were used for gene 
by gene analysis: a p-value ≤ 0.005 and a fold change ≥ 1.3. This more 
restrictive p-value implicated further reduction of more than 50% of the 
initial detected genes. 
 
 
Category N° lists Changed genes 
  p≤0.05 p≤0.005 
40 up-regulation 13 114 18 
Cellular Development 2 42 11 
Tissue Development 3 25 9 
Cellular Differentiation 2 27 5 
Cardiovascular Development 6 19 8 
    
40 down-regulation 7 152 50 
Phosphorylation 3 62 14 
Cellular Development 2 110 38 
Cellular Migration 1 61 26 
Anchoring junction 1 16 5 
    
80 up-regulation 4 4 3 
Extracellular Matrix Organization 2 2 2 
Cellular Development 2 2 1 
 
 
Table D. Best enrichment gene lists. The best outcomes of ToppGene Suite and IPA 
softwares (FDR B&H q-value < 0.01 and B-H p-value < 0.01, respectively), considering 
fold changes ≥ 1.3, the number of changed genes with p-value ≤ 0.05 and arbitrary p-
value ≤ 0.005, were illustrated.  
 
 
The total number of modulated genes belonging to 40 dependent down-
regulation (n=50) was bigger than the up-regulated condition (n=18), in 
contrast to the number of the relative total number of categories (n=13 for 
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40 up-regulation and n=7 for 40 down-regulation). These results were due 
to a redundancy of lots of genes. It was the case of genes like transcription 
and regulatory factors, phosphoproteins and kinases which are involved 
in multiple biological processes. Generally, 61% of 40 up-regulated genes 
and 44% of 40 down-regulated genes were annotated in regard only to an 
enrichment category.  
Concerning 80 up-regulated genes, the application of more restrictive 
parameters did not significantly modify their number (from initial 4 genes 
to 3 final genes).  
Finally, 8 differentially expressed genes after 40 QMR stimulation, 
considered the best genes in terms of significance, were in depth 
investigated in quantitative real time PCR (Table E). They were involved 
in biological processes related to cellular and tissue regeneration, like 
ECM remodeling, angiogenesis, cellular migration and regulation of actin 
filaments. Moreover, RUNX2 and SOX9, 2 genes involved in osteogenic 
and chondrogenic differentiation pathways were considered [62; 63]. 
By contrast, 3 differentially expressed genes obtained by 80 QMR 
treatment were not further investigated, due to the very low values 
compared to 40 setting.  
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Gene 
name P-value 
Fold 
change Protein name Function 
MMP1 0,00007 1,6 Interstitial collagenase Cleaves collagens of types I, II, and III 
PLAT 0,003 1,4 Tissue-type plasminogen activator Role in tissue remodeling 
SLIT2 0,003 1,3 Slit homolog 2 protein Molecular guidance in cellular migration 
ARHGAP22 0,004 1,3 Rho GTPase-activating protein 22 
Regulates endothelial cell 
capillary tube formation 
A2M 0,00005 -2,1 Alpha-2-macroglobulin Inhibitor of proteinases 
CORO1B 0,001 -1,4 Coronin-1B Regulates leading edge dynamics and cell motility 
SHC1 0,002 -1,5 SHC-transforming protein 1 Signaling adapter 
FN1 0,005 -1,4 Fibronectin Involved in cell adhesion and motility 
RUNX2 0,007 1,4 Runt-related transcription factor 2 
Transcription factor involved in 
osteoblastic differentiation 
SOX9 0,007 0,3 SRY-box 9 Regulates expression of genes involved in chondrogenesis 
 
Table E. Selected genes for testing microarray outcomes in quantitative real time PCR. 
The individuated genes took part to biological processes where MSC could have a role in 
the regenerative support or differentiation after QMR stimulation.  
 
 
4.8 Gene expression in quantitative real time PCR  
 
Quantitative real time PCR was carried out after treating MSC cultures at 
40 nominal power for 1 QMR cycle, to confirm the expression of 10 
interesting genes, including 6 genes up-regulated (MMP1, PLAT, SLIT2, 
ARHGAP22, RUNX2 and SOX9) and 4 down-regulated (A2M, CORO1B, 
SHC1, FN1).  
Our results, as shown in Figure 19, partially confirmed microarray results 
in gene expression. In particular MMP1, PLAT, ARHGAP22 and A2M 
revealed significant positive fold changes compared to the controls. By 
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contrast SLIT2, CORO1B, SHC1, FN1, RUNX2 and SOX9 were not found 
modulated by QMR treatment. 
 
 
 
Figure 19. Fold changes in gene expressions using quantitative real time PCR. 
Expression of 10 genes selected by microarray was illustrated after n=4 independent 
experiments; mean ± SEM; * p<0.05.  
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5. Discussion 
 
 
The present work was focused on understanding how QMR acts on 
human MSC. Actually, medical devices based on QMR are employed for 
the treatment of musculoskeletal disorders and post-surgical conditions 
[41; 42].  
In our experimental setting we have evidenced that the treatment with 
QMR do not alter morphology and do not induce cell death on MSC. 
Cellular proliferation and metabolic activity of treated cells were 
measured calculating population doubling at the end of each QMR cycle 
and by WST-1 assay respectively. Our data do not show any alteration of 
cellular proliferation or cellular metabolism after QMR stimulations.  
It has been evidenced that EMFs and electric fields have the capacity to 
modify cell physiology and signaling pathways altering ion channels, 
transport protein activation and intracellular ionic concentration [4; 64]. In 
particular some results suggest that EMFs affect early stages of 
differentiation and reduce the time of differentiation [65; 66]. Moreover, 
Teven and colleagues [67] have demonstrated that high frequency pulsed 
EMF stimulation augmented osteogenic differentiation. We have observed 
that the ability of MSC exposed to  QMR to generate mesodermal tissues 
(adipose tissue, bone, cartilage) was unaltered by the treatment.  Data was 
confirmed in quantitative real time PCR by an unaltered expression of 
RUNX2 and SOX9, early molecular markers of osteogenesis and 
chondrogenesis differentiation respectively. 
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The typical markers expressed by MSC like CD90, CD105 and CD73 were 
not altered after QMR stimulation, suggesting that the treatment has no 
effect on cellular phenotype. 
To investigate a possible effect of QMR at molecular level, we have 
performed gene expression profiling experiments. As expected for 
biological systems, microarray analysis revealed a high variability 
between the different MSC batches maybe explaining the observed 
functional differences between MSC subsets [68].  
DEG analysis revealed that MSC exposed at 40 QMR setting had more 
regulated genes suggesting that treatment at this nominal power is more 
effective than 80 in inducing molecular changes.  
The main biological processes affected by QMR stimulation revealed by 
functional analysis of gene lists [69; 70] belonged to development 
categories. In particular, 6 gene lists were related to cardiovascular 
development, cardiac differentiation and angiogenic response [14; 71].  
Gene by gene analysis also revealed that up- and down-regulated genes 
were involved in cellular and tissue regeneration processes such as ECM 
remodeling, angiogenesis, cellular migration and regulation of actin 
filaments.  
The most representative genes for each category were further validated in 
quantitative real time PCR on MSC exposed to 40 nominal power after a 
single QMR cycle. Overall, 40% of them comprising ARHGAP22, MMP1, 
PLAT and A2M showed statistical significance compared to controls. 
ARHGAP22 is gene expressing a RhoGAP cytoplasmic protein involved in 
angiogenesis and in the negative regulation of rearrangement of actin 
filaments through the inhibition of Rac1 [72; 73]. This data is interesting 
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since some frequencies produced by QMR treatment are inside the 
endogenous range that affect actin and microtubule filaments [1].  
Interestingly, up-regulated MMP1, PLAT and A2M genes are involved in 
the ECM remodeling through the fibrinolytic system that is also 
implicated in embryogenesis, wound healing and angiogenesis [74].  
PLAT is a serine protease that converts plasminogen into plasmin where 
the latter activates other proteases including MMP1 [74]. Neuss and 
collaborators [75] demonstrated that MSC are able to secrete enzymes 
involved into this biological pathway and our results showed its 
promotion by stimulated MSC. In particular the positive regulation of the 
two enzymes PLAT (upstream protein) and MMP1 (downstream protein) 
was in perfect combination with the negative regulation of the inhibitor of 
proteases A2M.  
Proteases participate in the regulation of angiogenesis through a 
modulation of an extremely complex process [76] whereas extracellular 
proteolysis is a requirement for new blood vessel formation. Therefore 
matrix metalloproteinases as well as plasminogen activator-plasmin 
systems play an important role during angiogenesis [77; 78].  
Other studies demonstrated a direct induction of angiogenic factors using 
electric current [79-81] and our results suggest that QMR promotes low 
release and bioavailability of factors stored in ECM reservoir [82-84] 
without a concomitant increase in the expression of these stimulators. For 
example, PLAT is able to activate platelet-derived growth factor C (PDGF-
C) [85].  
In conclusion, our data suggests that in our model QMR-treated MSC 
maintained unaltered cell phenotype, migration capacity, cell 
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proliferation, cell metabolism and the ability of MSC to differentiate into 
bone, cartilage and adipose tissue.  
Microarray analysis suggested that QMR treatment could improve 
angiogenesis and favor tissue regeneration probably through ECM 
remodeling. Further studies are needed to investigate the process at the 
protein level.  
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